| Product NDC: | 0067-6286 | 
| Proprietary Name: | Prevacid | 
| Non Proprietary Name: | Lansoprazole | 
| Active Ingredient(s): | 15 mg/1 & nbsp; Lansoprazole | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE, DELAYED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0067-6286 | 
| Labeler Name: | Novartis Consumer Health, Inc. | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | NDA022327 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20091112 | 
| Package NDC: | 0067-6286-28 | 
| Package Description: | 2 BOTTLE in 1 PACKAGE, COMBINATION (0067-6286-28) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE | 
| NDC Code | 0067-6286-28 | 
| Proprietary Name | Prevacid | 
| Package Description | 2 BOTTLE in 1 PACKAGE, COMBINATION (0067-6286-28) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE | 
| Product NDC | 0067-6286 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Lansoprazole | 
| Dosage Form Name | CAPSULE, DELAYED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20091112 | 
| Marketing Category Name | NDA | 
| Labeler Name | Novartis Consumer Health, Inc. | 
| Substance Name | LANSOPRAZOLE | 
| Strength Number | 15 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes |